Surmodics, Inc. (SRDX) Financials
Stock symbol SRDX is outdated, potentially delisted? Maybe it is available on other exchange?
SRDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 169.8 million | 58.5 million |
| March 31, 2025 | 163.2 million | 53.0 million |
| Dec. 31, 2024 | 163.7 million | 52.0 million |
| Sept. 30, 2024 | 178.6 million | 59.7 million |
SRDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | 904000 | 1.3 million |
| March 31, 2025 | 630000 | 1.4 million |
| Dec. 31, 2024 | -8.2 million | 1.7 million |
| Sept. 30, 2024 | 3.1 million | 2.1 million |
SRDX Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2025 | -5.3 million |
| March 31, 2025 | -5.2 million |
| Dec. 31, 2024 | -3.7 million |
| Sept. 30, 2024 | -3.4 million |
SRDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 32.7 million | 31.6 million | 1.9 million |
| March 31, 2025 | 31.1 million | 31.8 million | 3.2 million |
| Dec. 31, 2024 | 30.1 million | 32.0 million | 3.4 million |
| Sept. 30, 2024 | 40.1 million | 32.2 million | 3.7 million |
SRDX Shares Outstanding
SRDX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | 501000 | 3.1 million | 17.8 million | - |
| March 31, 2025 | 319000 | 3.2 million | 15.0 million | - |
| Dec. 31, 2024 | 302000 | 2.7 million | 15.2 million | - |
| Sept. 30, 2024 | 542000 | 2.7 million | 14.6 million | 1 |
SRDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | 29.6 million | 8.6 million |
| March 31, 2025 | 28.1 million | 7.8 million |
| Dec. 31, 2024 | 29.9 million | 7.4 million |
| Sept. 30, 2024 | 33.2 million | 8.7 million |
SRDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SRDX
Price: $42.98
52 week price:
Earnings Per Share: -1.24 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 34922
Ebitda: 887000Market Capitalization: 614.6 million